Could a sweat session rewrite breast cancer risk?
NCT ID NCT02494869
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study tests whether different amounts of progressive aerobic exercise can reduce risk factors for breast cancer in women who are at high risk. Participants will follow an exercise program, and researchers will measure changes in exercise capacity, body composition, and gene activity in breast tissue. The goal is to see if exercise can positively influence biological markers linked to cancer development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nonlinear aerobic training (a progressive exercise program)
- What this could lead to
- If exercise dose affects breast cancer risk factors, this could lead to tailored exercise prescriptions for prevention in high-risk women.
- What could go wrong
- The study is early and small, and results may not apply to all women. Exercise may not change risk factors as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK FOR DEVELOPING BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug shrink precancerous breast cells before surgery?
- Could a 'Baby Dose' of hormone pills prevent breast cancer?
- Study comparing Needle-Based breast lesion removal to surgery withdrawn before starting
- New shot aims to stop breast cancer before it starts
- New study tests skills training to help breast cancer survivors overcome Long-Term pain
- Baby tamoxifen shows promise in preventing breast cancer recurrence